NLRP3 and metabolic dysfunction-associated steatohepatitis: It is important to note that the development of type 2 diabetes, mitochondrial dysfunction, and insulin resistance are strongly associated with NLRP3 inflammasome activation, which are major risk factors for developing NASH [25, 26].